Please use this identifier to cite or link to this item: https://open.uns.ac.rs/handle/123456789/2875
DC FieldValueLanguage
dc.contributor.authorZorica Špirićen_US
dc.contributor.authorMirela Erićen_US
dc.contributor.authorŽivka Erien_US
dc.date.accessioned2019-09-23T10:24:18Z-
dc.date.available2019-09-23T10:24:18Z-
dc.date.issued2017-11-01-
dc.identifier.issn17486815en_US
dc.identifier.urihttps://open.uns.ac.rs/handle/123456789/2875-
dc.description.abstract© 2017 British Association of Plastic, Reconstructive and Aesthetic Surgeons Introduction Findings of the prognostic significance of lymphatic invasion are contradictory. To determine an as efficient cutaneous melanoma metastasis predictor as possible, Shields et al. created a new prognostic index. This study aimed to examine whether the lymphatic invasion analysis and the Shields index calculation can be used in predicting lymph node status in patients with cutaneous melanoma. Methods Lymphatic invasion of 100 melanoma specimens was detected by dual immunohistochemistry staining for the lymphatic endothelial marker D2-40 and melanoma cell S-100 protein. The Shields index was calculated as a logarithm by multiplying the melanoma thickness, square of peritumoural lymphatic vessel density and the number “2” for the present lymphatic invasion. Results No statistically significant difference was observed between lymph node metastatic and nonmetastatic melanomas regarding the lymphatic invasion. Metastatic melanomas showed a significantly higher Shields index value than nonmetastatic melanomas (p = 0.00). Area under the receiver operator characteristic (ROC) curve (AUC) proved that the Shields index (AUC = 0.86, 95% confidence interval (CI) 0.79–0.93, p = 0.00) was the most accurate predictor of lymph node status, followed by the melanoma thickness (AUC = 0.76, 95% CI 0.67–0.86, p = 0.00) and American Joint Committee on Cancer (AJCC) staging (AUC = 0.75, 95% CI 0.66–0.85, p = 0.00), while lymphatic invasion was not successful in predicting (AUC = 0.56, 95% CI 0.45–0.67, p = 0.31). The Shields index achieved 81.3% sensitivity and 75% specificity (cut-off mean value). Conclusions Our findings show that D2-40/S-100 immunohistochemical analysis of lymphatic invasion cannot be used for predicting the lymph node status, while the Shields index calculation predicts disease outcome more accurately than the melanoma thickness and AJCC staging.en_US
dc.language.isoenen_US
dc.relation.ispartofJournal of Plastic, Reconstructive and Aesthetic Surgeryen_US
dc.subjectImmunohistochemistryen_US
dc.subjectLymph node metastasisen_US
dc.subjectLymphatic invasionen_US
dc.subjectMelanomaen_US
dc.subjectPrognosisen_US
dc.titleLymphatic invasion and the Shields index in predicting melanoma metastasesen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.doi10.1016/j.bjps.2017.05.056-
dc.identifier.pmid70-
dc.identifier.scopus2-s2.0-85023183973-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85023183973-
dc.description.versionPublisheden_US
dc.relation.lastpage1652en_US
dc.relation.firstpage1646en_US
dc.relation.issue11en_US
dc.relation.volume70en_US
item.fulltextNo Fulltext-
item.grantfulltextnone-
crisitem.author.deptMedicinski fakultet, Katedra za anatomiju-
crisitem.author.orcid0000-0001-9214-384X-
crisitem.author.parentorgMedicinski fakultet-
Appears in Collections:MDF Publikacije/Publications
Show simple item record

SCOPUSTM   
Citations

4
checked on May 10, 2024

Page view(s)

26
Last Week
8
Last month
0
checked on May 10, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.